The precision with which some personal monitors perform their tasks is advancing rapidly, offering medical professionals much keener insight into what's happening with their patients. And while data behemoths Google, Apple and Amazon are driving much of the innovation, private companies are also making significant contributions.
Much of the research targets a group of chronic and pervasive diseases that are costly to treat — especially if they go undetected for too long — and that can be contained if detected early to reduce their toll on the patient. Among them: diabetes, cardiovascular diseases, asthma, Parkinson's disease and breast cancer.
Apple continues to pump out health-monitoring devices, and while its attempts to tap into the consumer market have had uneven results, the company's foray into the medical device realm appears to have brighter prospects.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.